INCY
Incyte CorporationNASDAQHealthcare$95.93+1.73%ClosedMarket Cap: $19.09B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
16
Sales
13
Buy/Sell Ratio
1.23
Total Bought
$0.00
Total Sold
$4.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 02 | HARRIGAN EDMUND | director | Sell | 269 | $94.12 | 21,122 |
| Thu Apr 02 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | Sell | 421 | $0.00 | 28,188,718 |
| Thu Apr 02 | Clancy Paul J | director | Sell | 265 | $94.12 | 23,741 |
| Thu Mar 26 | Trotta Matteo | officer: EVP, GM, Dermatology US | Sell | 537 | $92.23 | 14,882 |
| Thu Mar 19 | CAGNONI PABLO J | officer: President, R&D | Sell | 11,501 | $64.25 | 253,467 |
| Thu Mar 19 | CAGNONI PABLO J | officer: President, R&D | Sell | 7,166 | $61.18 | 241,966 |
| Thu Mar 19 | CAGNONI PABLO J | officer: President, R&D | Sell | 18,667 | $94.24 | 234,800 |
| Mon Feb 23 | CAGNONI PABLO J | officer: President, R&D | Sell | 18,668 | $100.91 | 234,800 |
| Mon Feb 23 | CAGNONI PABLO J | officer: President, R&D | Sell | 13,093 | $61.76 | 247,893 |
| Mon Feb 23 | CAGNONI PABLO J | officer: President, R&D | Sell | 5,575 | $61.18 | 253,468 |